AUM$1.6M
Expense Ratio0.70%
NAV$31.59
Holdings38
InceptionSep 29, 2022
Price Chart
Key Statistics
Previous Close
—Day Range
N/A52-Week Range
$24.57$31.73
Avg Volume
—Dividend Yield
—Expense Ratio
0.70%AUM
$1.6MShares Outstanding
—Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 61.86% |
| Basic Materials | 21.46% |
| Technology | 9.36% |
| Consumer Defensive | 5.83% |
| Consumer Cyclical | 1.49% |
Country Allocation
| Country | Weight % |
|---|---|
| Other | 100.00% |
Fund Information
- Issuer
- Franklin Templeton
- Category
- Healthcare
- Types
- Biotech
- Inception Date
- Sep 29, 2022
- Description
- The fund invests mainly in common stocks (growth or value stocks or both) of companies worldwide of any size with a focus on "biology revolution" companies. From time to time, the fund may invest a significant portion of its assets in companies in one or more related industries or sectors, including the health care, consumer discretionary, consumer staples, biotechnology and materials sectors. The fund is non-diversified.
Similar ETFs
The Putnam BioRevolution ETF (SYNB) is an exchange-traded fund issued by Franklin Templeton that launched on Sep 29, 2022. It currently manages $1.6M in assets under management. The fund charges an expense ratio of 0.70%. The fund holds 38 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 100.0% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | PGLXX | PUTNAM GOVT MMKT FND-P | 99.92% | 1,578,808 | $1.6M |
| 2 | — | Net Current Assets | 0.07% | 1 | $1K |
| 3 | — | CASH | 0.01% | 185 | $185 |
| 4 | — | TRUSTEE DEFERRED COMP A/D | 0.00% | 1 | $0 |
| 5 | — | TRUSTEE DEFERRED COMP PAY | 0.00% | 1 | $0 |
Detailed Returns
| Period | Return | ETF | Cat. Avg | vs Avg |
|---|---|---|---|---|
| 1D | — | — | ||
| 1W | — | — | ||
| 1M | — | — | ||
| 3M | — | — | ||
| 6M | +5.42% | — | ||
| YTD | — | — | ||
| 1Y | +10.15% | — | ||
| 3Y | +22.25% | — | ||
| 5Y | +27.48% | — |
Moving Averages
20-Day MA
—
50-Day MA
—
200-Day MA
—
Price with Moving Averages
Support & Resistance
52-Week High
$31.73
Current Price
—
52-Week Low
$24.57
Current Yield
—
Annual Dividend
—
Frequency
—
Last Ex-Date
—
Dividends
No dividend data available for this ETF.
Category Comparison
| Metric | SYNB | Healthcare(223 ETFs) | Biotech(41 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.70% | 0.60% | 0.83% |
| AUM | $1.6M | $1.24B | $1.51B |
| Dividend Yield | — | 2.75% | 2.14% |
| Avg Volume | — | 800.9K | 1.3M |
| Holdings | 38 | 171 | 66 |
| Performance | |||
| 1-Month Return | — | -4.57% | -3.93% |
| 6-Month Return | — | +4.90% | +15.68% |
| YTD Return | — | -1.70% | -2.78% |
| 1-Year Return | — | +15.18% | +25.33% |
Compare with Another ETF
Search for an ETF to compare with SYNB: